Location History:
- Oberwil, CH (2002 - 2020)
- Basel, CH (2019 - 2022)
Company Filing History:
Years Active: 2002-2022
Title: Gerhard Penn: Innovator in Chemical Synthesis
Introduction
Gerhard Penn is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of chemical synthesis, particularly in the development of neprilysin inhibitors. With a total of 8 patents to his name, his work has had a substantial impact on pharmaceutical chemistry.
Latest Patents
Among his latest patents, Gerhard has focused on processes and intermediates for the synthesis of neprilysin (NEP) inhibitors, specifically sacubitril. His inventions relate to new chemical synthesis methods, intermediates, and catalysts that are essential for the preparation of these inhibitors. These patents also introduce new intermediate compounds and their applications in innovative chemical synthesis routes.
Career Highlights
Gerhard has had a distinguished career, working with prominent companies such as Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to refine his expertise in chemical synthesis and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Throughout his career, Gerhard has collaborated with talented individuals, including Florian Karl Kleinbeck-Riniker and Benjamin Martin. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.
Conclusion
Gerhard Penn's contributions to chemical synthesis and his innovative patents highlight his role as a leading inventor in the pharmaceutical field. His work continues to influence the development of important medical therapies.